Janux Therapeutics
Peter Folger has worked in the field of clinical research for over a decade. Peter began their career in 2010 as a Senior Associate Scientist at Chromocell Corporation. In 2014, they moved to Pfizer as an Associate Scientist. From 2015 to 2022, they worked at Aptose Biosciences, Inc. as both a Clinical Research Associate and a Research Associate. Peter is currently employed as a Senior Clinical Research Associate at Janux Therapeutics.
Peter Folger graduated from Penn State University in 2009 with a Bachelor of Science (B.S.) in Molecular Biology.
Janux Therapeutics
1 followers
Janux Therapeutics is developing safe, effective novel immunotherapies with the company’s proprietary TRACTr technology. Janux’s TRACTr technology employs a modular design to rapidly engineer drug candidates against specific targets.